source
- Pfizer CEO says Democratic gains unlikely to alter Trump-era MFN pricing agreementsPfizer chief Albert Bourla told reporters that he does not anticipate any changes to the most‑favored‑nation pricing arrangements that were put in place under the Trump administration, even if the…
- Novartis ends discovery-stage collaboration with BioArctic amid broader biotech updatesNovartis announced it is terminating its discovery-stage partnership with Swedish biotech BioArctic. The decision ends joint work that was focused on early‑stage research. BioArctic is best known…